BioClinica Inc (NASDAQ:BIOC) Investor Files Lawsuit to Halt Acquisition Attempt by JLL Partners
February 13, 2013 at 08:10 AM EST
San Diego, CA -- (SBWIRE) -- 02/13/2013 -- An investor in shares of BioClinica Inc (NASDAQ:BIOC) filed a lawsuit to halt the proposed takeover of BioClinica Inc by JLL Partners, Inc at $7.25 per NASDAQ:BIOC share.